search
Back to results

Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation

Primary Purpose

Functional Constipation

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Electroacupuncture
TranscutaneousElectricNerveStimulation
Sponsored by
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Functional Constipation focused on measuring acupuncture, functional constipation, transcutaneous electric nerve stimulation, randomized controlled trial

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Conforming to the criteria for the diagnosis of functional constipation in Rome III standard;
  2. Aged of 18 to 75 years;
  3. No medication for constipation has been used for at least 2 weeks before treatment. Except for emergency treatment, it has not received acupuncture treatment for constipation in the past 3 months, and has not participated in other ongoing clinical research.

Exclusion Criteria:

  1. Constipation caused by irritable bowel syndrome and organically or medicated; secondary to endocrine, metabolic, neurogenic, or surgical constipation;
  2. Subjects with serious heart, liver, kidney damage or cognitive impairment, aphasia, mental disorders, or the inability to cooperate with the examination and treatment.
  3. Pregnant or lactation patients;
  4. Subjects with abdominal aortic aneurysm, abnormal enlargement of liver and spleen and so on.
  5. Subjects with coagulation dysfunction or anticoagulants such as warfarin and heparin have been used all the time.
  6. Subjects installed with the cardiac pacemaker.

Sites / Locations

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Electroacupuncture

TranscutaneousElectricNerveStimulation

Arm Description

The treatment consists of 3 times a week for 8 weeks.Huatuo Brand needles (0.30×50mm or 0.30×70mm) and the SDZ-V EA apparatus (Suzhou Medical Appliance) will be used for ST25, SP14 and ST37.After acupuncture,the needle handle will be connected with the electrode in the electroacupuncture instrument. The parameters of the electric acupuncture apparatus:Dilatational wave,the frequency is 2/10Hz,the electric current intensity is 0.1mA-1.0mA.

The treatment consists of 3 times a week for 8 weeks.Huatuo Brand electrode patch (50mm×50mm) and the SDZ-V EA apparatus (Suzhou Medical Appliance) will be used for ST25, SP14 and ST37. The parameters of the electric acupuncture apparatus:Dilatational wave,the frequency is 2/10Hz,the electric current intensity is 2mA-5mA.

Outcomes

Primary Outcome Measures

The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at week 8.
The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at week 8.

Secondary Outcome Measures

The proportion of participants with an average increasing of one or more complete spontaneous bowel movements
The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at weeks 4 , 20 and 32.
Change number in CSBMS
The change in the number of CSBMs at weeks 4 , 8 , 20 and 32.
Change number in SBMS
The change in the number of SBMs at weeks 4 , 8 , 20 and 32.
The proportion of participants with type3 or type 4 stool character
According to the BRISTOL stool form scale, the proportion of participants with type3 or type 4 at weeks 4 , 8 , 20 and 32
Change number of average score in defecation difficulty
The change in average score of difficulty in defecation at weeks 4 , 8 , 20 and 32
Change number of PAC-QOL score
The change in total score on the patients assessment of constipation quality of life questionnaire(PAC-QOL) total score at the end of week 8, compared with baseline.
The proportion and average amount of using cathartics
The proportion and average amount of using cathartics at weeks -1 , 4 , 8 , 20 and 32.

Full Information

First Posted
December 22, 2017
Last Updated
March 14, 2022
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT03391635
Brief Title
Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation
Official Title
Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation:a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
July 1, 2018 (Actual)
Primary Completion Date
December 30, 2019 (Actual)
Study Completion Date
December 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The objective of this trial is to compare the efficacy of electroacupuncture versus transcutaneous electric nerve stimulation for functional constipation
Detailed Description
Both electroacupuncture(EA) therapy and transcutaneous electric nerve stimulation(TENS) are safe and effective for functional constipation, but no head to head comparing trial was conducted. Methods:102 participants with functional constipation will be recruited and randomly allocated into the EA group and the TENS group.Participants in both groups will receive EA or TENS treatment at Tianshu(ST 25), Fujie(SP 14) and Shangju xu(ST 37) 3 times a week for 8 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Functional Constipation
Keywords
acupuncture, functional constipation, transcutaneous electric nerve stimulation, randomized controlled trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Electroacupuncture
Arm Type
Experimental
Arm Description
The treatment consists of 3 times a week for 8 weeks.Huatuo Brand needles (0.30×50mm or 0.30×70mm) and the SDZ-V EA apparatus (Suzhou Medical Appliance) will be used for ST25, SP14 and ST37.After acupuncture,the needle handle will be connected with the electrode in the electroacupuncture instrument. The parameters of the electric acupuncture apparatus:Dilatational wave,the frequency is 2/10Hz,the electric current intensity is 0.1mA-1.0mA.
Arm Title
TranscutaneousElectricNerveStimulation
Arm Type
Active Comparator
Arm Description
The treatment consists of 3 times a week for 8 weeks.Huatuo Brand electrode patch (50mm×50mm) and the SDZ-V EA apparatus (Suzhou Medical Appliance) will be used for ST25, SP14 and ST37. The parameters of the electric acupuncture apparatus:Dilatational wave,the frequency is 2/10Hz,the electric current intensity is 2mA-5mA.
Intervention Type
Device
Intervention Name(s)
Electroacupuncture
Other Intervention Name(s)
EA
Intervention Description
Participants will receive electroacupuncture at bilateral ST25, SP14 and ST37 for 30 minutes each time,3 times a week for 8 weeks.
Intervention Type
Device
Intervention Name(s)
TranscutaneousElectricNerveStimulation
Other Intervention Name(s)
TENS
Intervention Description
Participants will receive transcutaneous electric nerve stimulation at bilateral ST25, SP14 and ST37 for 30 minutes each time,3 times a week for 8 weeks.
Primary Outcome Measure Information:
Title
The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at week 8.
Description
The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at week 8.
Time Frame
Baseline,week 8
Secondary Outcome Measure Information:
Title
The proportion of participants with an average increasing of one or more complete spontaneous bowel movements
Description
The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at weeks 4 , 20 and 32.
Time Frame
Baseline,week 4,week 20 and week 32
Title
Change number in CSBMS
Description
The change in the number of CSBMs at weeks 4 , 8 , 20 and 32.
Time Frame
Baseline,week 4,week 8, week 20 and week 32
Title
Change number in SBMS
Description
The change in the number of SBMs at weeks 4 , 8 , 20 and 32.
Time Frame
Baseline,week 4,week 8, week 20 and week 32
Title
The proportion of participants with type3 or type 4 stool character
Description
According to the BRISTOL stool form scale, the proportion of participants with type3 or type 4 at weeks 4 , 8 , 20 and 32
Time Frame
Baseline,week 4,week 8, week 20 and week 32
Title
Change number of average score in defecation difficulty
Description
The change in average score of difficulty in defecation at weeks 4 , 8 , 20 and 32
Time Frame
Baseline,week 4,week 8, week 20 and week 32
Title
Change number of PAC-QOL score
Description
The change in total score on the patients assessment of constipation quality of life questionnaire(PAC-QOL) total score at the end of week 8, compared with baseline.
Time Frame
Baseline,week 8
Title
The proportion and average amount of using cathartics
Description
The proportion and average amount of using cathartics at weeks -1 , 4 , 8 , 20 and 32.
Time Frame
weeks -1 , 4 , 8 , 20 and 32.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Conforming to the criteria for the diagnosis of functional constipation in Rome III standard; Aged of 18 to 75 years; No medication for constipation has been used for at least 2 weeks before treatment. Except for emergency treatment, it has not received acupuncture treatment for constipation in the past 3 months, and has not participated in other ongoing clinical research. Exclusion Criteria: Constipation caused by irritable bowel syndrome and organically or medicated; secondary to endocrine, metabolic, neurogenic, or surgical constipation; Subjects with serious heart, liver, kidney damage or cognitive impairment, aphasia, mental disorders, or the inability to cooperate with the examination and treatment. Pregnant or lactation patients; Subjects with abdominal aortic aneurysm, abnormal enlargement of liver and spleen and so on. Subjects with coagulation dysfunction or anticoagulants such as warfarin and heparin have been used all the time. Subjects installed with the cardiac pacemaker.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yuxiao Zeng
Organizational Affiliation
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
City
Beijing
ZIP/Postal Code
100053
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21382575
Citation
Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011 Feb;25(1):3-18. doi: 10.1016/j.bpg.2010.12.010.
Results Reference
result
PubMed Identifier
16000928
Citation
Tran LC, Di Palma JA. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation. J Clin Gastroenterol. 2005 Aug;39(7):600-2. doi: 10.1097/01.mcg.0000170769.67320.47.
Results Reference
result
PubMed Identifier
22786523
Citation
Gordon M, Naidoo K, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009118. doi: 10.1002/14651858.CD009118.pub2.
Results Reference
result
PubMed Identifier
17464377
Citation
Pare P, Bridges R, Champion MC, Ganguli SC, Gray JR, Irvine EJ, Plourde V, Poitras P, Turnbull GK, Moayyedi P, Flook N, Collins SM. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol. 2007 Apr;21 Suppl B(Suppl B):3B-22B.
Results Reference
result
PubMed Identifier
21205879
Citation
Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011 Feb;60(2):209-18. doi: 10.1136/gut.2010.227132.
Results Reference
result
PubMed Identifier
17497967
Citation
Wong SW, Lubowski DZ. Slow-transit constipation: evaluation and treatment. ANZ J Surg. 2007 May;77(5):320-8. doi: 10.1111/j.1445-2197.2007.04051.x.
Results Reference
result
PubMed Identifier
26537099
Citation
Pfeifer J. Surgical options to treat constipation: A brief overview. Rozhl Chir. 2015 Sep;94(9):349-61.
Results Reference
result
PubMed Identifier
21724490
Citation
Remes Troche JM, Gomez Escudero O, Icaza Chavez ME, Noble Lugo A, Lopez Colombo A, Bielsa MV, Charua Guindic L; Asociacion Mexicana de Gastroenterologia. [Guidelines for diagnosis and treatment of constipation in Mexico. C) Medical and surgical treatment]. Rev Gastroenterol Mex. 2011 Apr-Jun;76(2):141-54. Spanish.
Results Reference
result
PubMed Identifier
22295840
Citation
Du WF, Yu L, Yan XK, Wang FC. [Met-analysis on randomized controlled clinical trials of acupuncture and moxibustion on constipation]. Zhongguo Zhen Jiu. 2012 Jan;32(1):92-6. Chinese.
Results Reference
result
PubMed Identifier
27618593
Citation
Liu Z, Yan S, Wu J, He L, Li N, Dong G, Fang J, Fu W, Fu L, Sun J, Wang L, Wang S, Yang J, Zhang H, Zhang J, Zhao J, Zhou W, Zhou Z, Ai Y, Zhou K, Liu J, Xu H, Cai Y, Liu B. Acupuncture for Chronic Severe Functional Constipation: A Randomized Trial. Ann Intern Med. 2016 Dec 6;165(11):761-769. doi: 10.7326/M15-3118. Epub 2016 Sep 13.
Results Reference
result
PubMed Identifier
16678553
Citation
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. doi: 10.1053/j.gastro.2006.03.008. No abstract available.
Results Reference
result
PubMed Identifier
9299672
Citation
Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920-4. doi: 10.3109/00365529709011203.
Results Reference
result
PubMed Identifier
16036506
Citation
Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005 May;40(5):540-51. doi: 10.1080/00365520510012208.
Results Reference
result
PubMed Identifier
29166673
Citation
Yang X, Liu Y, Liu B, He L, Liu Z, Yan Y, Liu J, Liu B. Factors related to acupuncture response in patients with chronic severe functional constipation: Secondary analysis of a randomized controlled trial. PLoS One. 2017 Nov 22;12(11):e0187723. doi: 10.1371/journal.pone.0187723. eCollection 2017.
Results Reference
result
PubMed Identifier
20006033
Citation
Ismail KA, Chase J, Gibb S, Clarke M, Catto-Smith AG, Robertson VJ, Hutson JM, Southwell BR. Daily transabdominal electrical stimulation at home increased defecation in children with slow-transit constipation: a pilot study. J Pediatr Surg. 2009 Dec;44(12):2388-92. doi: 10.1016/j.jpedsurg.2009.07.063.
Results Reference
result
PubMed Identifier
19524752
Citation
Clarke MC, Chase JW, Gibb S, Hutson JM, Southwell BR. Improvement of quality of life in children with slow transit constipation after treatment with transcutaneous electrical stimulation. J Pediatr Surg. 2009 Jun;44(6):1268-72; discussion 1272. doi: 10.1016/j.jpedsurg.2009.02.031.
Results Reference
result

Learn more about this trial

Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation

We'll reach out to this number within 24 hrs